JP2023535224A5 - - Google Patents

Info

Publication number
JP2023535224A5
JP2023535224A5 JP2023505377A JP2023505377A JP2023535224A5 JP 2023535224 A5 JP2023535224 A5 JP 2023535224A5 JP 2023505377 A JP2023505377 A JP 2023505377A JP 2023505377 A JP2023505377 A JP 2023505377A JP 2023535224 A5 JP2023535224 A5 JP 2023535224A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
disease
formula
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023505377A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023535224A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/043230 external-priority patent/WO2022026417A1/en
Publication of JP2023535224A publication Critical patent/JP2023535224A/ja
Publication of JP2023535224A5 publication Critical patent/JP2023535224A5/ja
Pending legal-status Critical Current

Links

JP2023505377A 2020-07-26 2021-07-26 新規使用 Pending JP2023535224A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063056706P 2020-07-26 2020-07-26
US63/056,706 2020-07-26
PCT/US2021/043230 WO2022026417A1 (en) 2020-07-26 2021-07-26 Novel uses

Publications (2)

Publication Number Publication Date
JP2023535224A JP2023535224A (ja) 2023-08-16
JP2023535224A5 true JP2023535224A5 (https=) 2024-07-30

Family

ID=80036116

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023505377A Pending JP2023535224A (ja) 2020-07-26 2021-07-26 新規使用

Country Status (4)

Country Link
US (1) US20240009195A1 (https=)
EP (1) EP4188353A4 (https=)
JP (1) JP2023535224A (https=)
WO (1) WO2022026417A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220280517A1 (en) * 2019-08-22 2022-09-08 Intra-Cellular Therapies, Inc. Organic compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006255028B2 (en) * 2005-06-06 2012-04-19 Intra-Cellular Therapies, Inc. Organic compounds
WO2013106547A1 (en) * 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
US9630971B2 (en) * 2013-06-21 2017-04-25 Intra-Cellular Therapies, Inc. Free base crystals
CN107787322B (zh) * 2015-06-17 2023-07-07 辉瑞大药厂 三环化合物以及它们作为磷酸二酯酶抑制剂的用途
WO2017203229A1 (en) * 2016-05-27 2017-11-30 Cipla Limited Dapagliflozin premixes
JP7401442B2 (ja) * 2018-01-31 2023-12-19 イントラ－セルラー・セラピーズ・インコーポレイテッド 新規使用

Similar Documents

Publication Publication Date Title
JP5320399B2 (ja) １，３，５−トリアジン−２，４，６−トリアミン化合物またはその薬学的に許容可能な塩と、それを含む薬学組成物
KR100883461B1 (ko) 혈중 콜레스테롤 농도 저하제로서 유용한 당-치환된2-아제티딘온
JP2019531320A5 (https=)
KR20040025915A (ko) 디펩티딜 펩티다아제 ｉｖ의 저해제를 이용한 2형당뇨병의 치료
JP2011527675A5 (https=)
HU230609B1 (hu) Hipolipidémiás és hipokoleszterinémiás hatású szubsztituált pirrolszármazékok, azokat tartalmazó gyógyszerkészítmények, eljárás előállításukra, köztitermékek és alkalmazásuk
JP2009501776A (ja) 遊離脂肪酸に起因した障害におけるチアゾール誘導体およびアナログの使用
JP2023535224A5 (https=)
JP2026062985A (ja) 非アルコール性脂肪性肝炎（ｎａｓｈ）、肝炎、肝細胞バルーニング、肝線維症及び脂肪症の治療に使用するための（ｓ）－２－アミノ－６－（（３－アミノプロピル）アミノ）ヘキサン酸（ａｐｌ）
JP5877709B2 (ja) ３−（４−アミノフェニル）−２−フランカルボン酸誘導体およびその薬学的に許容される塩
JP2021520394A5 (https=)
JP2011515406A (ja) 治療用の置換シクロペンタン類
WO2014049515A1 (en) Pyrrolidine substituted flavones for treatment of renal cystic diseases
KR20190113623A (ko) (2e,4e)-5-페닐-펜타-2,4-다이엔-1-온 유도체
US20120046317A1 (en) Novel heterocyclic compounds
CN118340754A (zh) 治疗心衰及其相关疾病的化合物和应用
CN101237866A (zh) 噻唑类衍生物和类似物在游离脂肪酸引起的疾病中的应用
JP2023002841A (ja) 高血圧症及び／又は線維症を処置するための組成物
WO2002022074A2 (fr) Utilisation de 2- et 4-quinolones pour inhiber la neo-proliferation intimale
US20250376466A1 (en) Ester compounds and use thereof
JP2022545802A5 (https=)
JPH1067733A5 (https=)
CN121990979A (zh) 一类化合物及其在制备抗衰老药物中的用途
EP4686469A1 (en) Cxcl8 inhibitors for use in the treatment of diabetes-associated comorbidities
RU2021122314A (ru) Антигипертензивное полиольное соединение и его производное